Today in the Conference Coverage section of the CLL Society website cllsociety.org , we’ve posted a summary and link to the ASH abstract we wrote based on the results from our Reader Poll in the Q1 2016 issue of The CLL Tribune where we asked you about what was important to you when making treatment decisions for your CLL. You can view my article and see the abstract here.
Leaving on a jet plane again. Economy class. Red-eye. Tight connection in Germany. Leave on one day, arrive the next in Belgrade. Landing at the Nicolas Tesla Airport.
This is yet another familiar story as I’m packing my bags to attend the 2016 CLL Horizons meeting in Serbia this week. I will serve as faculty and part of the steering committee for the newly forming CLL Advocacy Network, a global network of organizations representing people with CLL. The main goal of this first CLL Horizons conference is to build capacity for international patient advocacy organizations to support people affected by CLL. This is important work and our own Nick York of CLLSA in the UK who is chairing the meeting is to be applauded for his hard work in making this happen.
Post-ASH CLL Patient Educational Forum at City of Hope, Duarte , CA. USA
We're excited to announce that on Saturday, December 17th, in partnership with City of Hope Medical Center and the Leukemia and Lymphoma Society, the CLL Society will be hosting the second annual Post-ASH CLL Educational Forum at City of Hope. Dr. Tanya Siddiqi will be presenting on the latest data on Diagnosis and Frontline Treatment and Dr. Steven Rosen will present on Relapsed Disease and Novel Therapies. You can access the flyer on our website and pre-registration is requested. We look forward to seeing you there.
In the meantime….
We are all in this together.
Brian Koffman, MD